Primary extraosseous Ewing sarcoma of the orbit

Ophthalmic Plast Reconstr Surg. 2013 May-Jun;29(3):e91-3. doi: 10.1097/IOP.0b013e3182771549.

Abstract

A 40-year-old man presented with painless, progressive vision loss and mild proptosis of the OD. CT revealed a right intraconal mass with slight penetration of the optic canal not contiguous with any bony structure. Incisional biopsy through a transfrontal orbitotomy revealed a diffuse growth of homogeneous, small, round cells. Immunohistochemical stains were positive for vimentin and MIC2 (CD99), and the translocation at EWS gene (22q12) was detected. Metastatic workup and a full-body bone scan were negative, confirming primary orbital extraosseous Ewing sarcoma. The patient received neoadjuvant chemotherapy and an orbital exenteration with preservation of eyelids and conjunctiva. He also received adjuvant chemotherapy and local radiotherapy, and he has remained disease-free for almost 3 years.

Publication types

  • Case Reports

MeSH terms

  • 12E7 Antigen
  • Adult
  • Antigens, CD / metabolism
  • Biomarkers, Tumor / metabolism
  • Cell Adhesion Molecules / metabolism
  • Chromosomes, Human, Pair 22 / genetics
  • Combined Modality Therapy
  • Exophthalmos / diagnosis
  • Humans
  • In Situ Hybridization, Fluorescence
  • Male
  • Neoadjuvant Therapy
  • Orbit Evisceration
  • Orbital Neoplasms / metabolism
  • Orbital Neoplasms / pathology*
  • Orbital Neoplasms / therapy
  • Plastic Surgery Procedures
  • Sarcoma, Ewing / metabolism
  • Sarcoma, Ewing / pathology*
  • Sarcoma, Ewing / therapy
  • Tomography, X-Ray Computed
  • Translocation, Genetic
  • Vimentin / metabolism
  • Vision Disorders / diagnosis

Substances

  • 12E7 Antigen
  • Antigens, CD
  • Biomarkers, Tumor
  • CD99 protein, human
  • Cell Adhesion Molecules
  • Vimentin